Log in

603168 Zhejiang Shapuaisi Pharmaceutical Co. Ltd. SSE · China

Zhejiang Shapuaisi Pharmaceutical Co. (603168) news

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 603168, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Zhejiang Shapuaisi Pharmaceutical Co. news

We have not published a story on Zhejiang Shapuaisi Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Zhejiang Shapuaisi Pharmaceutical Co.

What is the ticker symbol of Zhejiang Shapuaisi Pharmaceutical Co.?

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. trades under the ticker 603168 on SSE.

Where is Zhejiang Shapuaisi Pharmaceutical Co. listed?

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. is listed on SSE.

Which country or territory is Zhejiang Shapuaisi Pharmaceutical Co. listed under?

Our directory records Zhejiang Shapuaisi Pharmaceutical Co. Ltd. under China.

What does Zhejiang Shapuaisi Pharmaceutical Co. do?

Our directory classifies Zhejiang Shapuaisi Pharmaceutical Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Zhejiang Shapuaisi Pharmaceutical Co.?

The ISIN recorded for Zhejiang Shapuaisi Pharmaceutical Co. Ltd. is CNE100001TG0.

Does aibio.space cover Zhejiang Shapuaisi Pharmaceutical Co.?

aibio.space lists Zhejiang Shapuaisi Pharmaceutical Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Zhejiang Shapuaisi Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Zhejiang Shapuaisi Pharmaceutical Co.: Wuhan YZY Biopharma Co., Harbin Medisan Pharmaceutical Co., Kexing Biopharm Co., Shanghai Allist Pharmaceuticals Co., North China Pharmaceutical Company, Yunnan Baiyao Group Co..

Investor discussion: Zhejiang Shapuaisi Pharmaceutical Co.

Members talk about Zhejiang Shapuaisi Pharmaceutical Co. (603168). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:603168 on TradingView.

Listing details

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 603168, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Zhejiang Shapuaisi Pharmaceutical Co. Ltd.
Ticker
603168
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE100001TG0
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.